Trial · NCT01975519
Adverse events230
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 230
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Fatigue | General disorders | 8 mg/kg TRC105 + Pazopanib | 2 | 3 | |
| other | Fatigue | General disorders | 10 mg/kg TRC105 + Pazopanib | 80 | 106 | |
| other | Headache | Nervous system disorders | 8 mg/kg TRC105 + Pazopanib | 2 | 3 | |
| other | Headache | Nervous system disorders | 10 mg/kg TRC105 + Pazopanib | 75 | 106 | |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | 8 mg/kg TRC105 + Pazopanib | 3 | 3 | |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | 10 mg/kg TRC105 + Pazopanib | 73 | 106 | |
| other | Nausea | Gastrointestinal disorders | 8 mg/kg TRC105 + Pazopanib | 2 | 3 | |
| other | Nausea | Gastrointestinal disorders | 10 mg/kg TRC105 + Pazopanib | 66 | 106 | |
| other | Diarrhea | Gastrointestinal disorders | 8 mg/kg TRC105 + Pazopanib | 3 | 3 | |
| other | Diarrhea | Gastrointestinal disorders | 10 mg/kg TRC105 + Pazopanib | 64 | 106 | |
| other | Vomiting | Gastrointestinal disorders | 8 mg/kg TRC105 + Pazopanib | 1 | 3 | |
| other | Vomiting | Gastrointestinal disorders | 10 mg/kg TRC105 + Pazopanib | 52 | 106 | |
| other | Decreased Appetite | Metabolism and nutrition disorders | 8 mg/kg TRC105 + Pazopanib | 2 | 3 | |
| other | Decreased Appetite | Metabolism and nutrition disorders | 10 mg/kg TRC105 + Pazopanib | 47 | 106 | |
| other | Hypertension | Vascular disorders | 8 mg/kg TRC105 + Pazopanib | 2 | 3 | |
| other | Hypertension | Vascular disorders | 10 mg/kg TRC105 + Pazopanib | 46 | 106 | |
| other | Anemia | Blood and lymphatic system disorders | 8 mg/kg TRC105 + Pazopanib | 1 | 3 | |
| other | Anemia | Blood and lymphatic system disorders | 10 mg/kg TRC105 + Pazopanib | 45 | 106 | |
| other | Gingival Bleeding | Gastrointestinal disorders | 8 mg/kg TRC105 + Pazopanib | 2 | 3 | |
| other | Gingival Bleeding | Gastrointestinal disorders | 10 mg/kg TRC105 + Pazopanib | 40 | 106 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01975519/events